Loading upAs we inch closer to the May judgement with Shiseido- I will be curious how that affects the stock price. I'm likely a buyer in April hoping for a positive outcome in the chance Replicel & Shiseido come to an agreement earlier and/or a favorable outcome
I'm still a firm believer of the following in the stock price
1. The device $1-2
2. A positive outcome with Shiseido $2-3 (incremental).
3. If the data is REALLY good from Shiseido strap in, I trust the Replicel team will get investors galore wanting a piece of it. I see a $12-15 stock price from there
many "if's" remain - but that's what you get when you invest in a pre revenue company. I trust the fact Andrew and team are feeling awfully confident given their latest investments
but "when" it hits, better take a few days off work bc there's no chance you'll be able to concentrate on anything other than all the money you're raking in
here's to a great 2023 for Replicel and our shares.